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A B S T R A C T
Leishmaniasis is a vector-borne disease caused by protozoan parasites from the genus Leishmania. The most
severe form of disease is visceral leishmaniasis (VL), which is fatal if left untreated. It has been demonstrated that
interleukin (IL)-10, is associated with disease progression and susceptibility. In this work, we took advantage of a
transgenic mouse model that expresses high levels of IL-10 upon zinc sulfate administration (pMT-10). We
addressed the role of IL-10 during the initial stages of L. donovani infection by analyzing the parasite burden in
the spleen and liver of the infected pMT-10 and WT mice as well as the histopathological alterations upon IL-10
induction. Furthermore, the proﬁle of cytokines expressed by T cells was assessed. Our results demonstrate that
an increase in IL-10 production has an impact early but not later after infection. This speciﬁc temporal role for
IL-10-mediated susceptibility to VL is of interest.
1. Introduction (1896)
Leishmaniasis is a group of tropical neglected diseases caused by
protozoan parasites from the genus Leishmania, which range from self-
healing cutaneous lesions to fatal visceral disease. Leishmania donovani
is one of the causative agents of visceral leishmaniasis (VL) responsible
for high morbidity and mortality in East Africa and South Asia [13].
Immunity to VL has long been known to depend on the development of
type I immune responses characterized by initial production of inter-
leukin-12 (IL-12) by antigen-presenting cells (APCs) that induce inter-
feron-γ (IFN-γ)-secreting Th1 T cells [11]. These, in turn, will activate
and prime host innate cells for the production of microbicidal molecules
as reactive nitrogen and oxygen species (RNS and ROS, respectively).
However, the presence of a Th1 response does not immediately corre-
late with protection, whose action is neutralized by immune regulatory
factors [11]. Among those, the role of IL-10 as a major mediator in the
suppression of a leishmanicidal immune response has gained a parti-
cular attention in the past [1,4,7,8,9],. IL-10 is an anti-inﬂammatory
cytokine induced during experimental and human infections [7], whose
levels correlate with disease severity [5,14]. IL-10 has the potential to
disable host anti-leishmanial defense and foster visceral infection by
compromising Th1 responses and deactivating host phagocytes [4,8],.
In contrary, mice deﬁcient in IL-10 or in which IL-10 signaling is
blocked are highly resistant to Leishmania infection [11]. Yet, the re-
levance of IL-10 production during the initial innate immune response
or upon the establishment of an adaptive immune response is still un-
known. Since a coordinated inﬂammatory response is the hallmark of a
protective immune response to infection, we evaluate the early impact
of IL-10 expression before or after the onset of a Leishmania-speciﬁc
adaptive immune response. To address this issue, we took advantage of
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the pMT-10 mouse model, in which IL-10 was induced by zinc sulfate
administration. Herein, we show that overexpression of IL-10 during
the initial steps of infection underlies susceptibility to L. donovani in-
fection, by modulating the expansion of multifunctional CD4 T cells.
2. Material and methods
2.1. Animals
pMT-10 on a C57BL/6 background and C57BL/6 mice were main-
tained under speciﬁc pathogen-free at the Life and Health Sciences
Research Institute (ICVS, Braga, Portugal) and allowed food and water
ad libitum. Animals with eight to twelve weeks were used in the ex-
periments. Experimental animal procedures agreed with the European
Council Directive (2010/63/EU) guidelines that where transposed into
Portuguese law (Decree-Law no. 113/2013, August 7th). Additionally,
the experiments were conducted with the approval of the UMinho
Ethical Committee (process no. SECVS 074/2016) and complied with
the guidelines of the Committee and National Council of Ethics for the
Life Sciences (CNECV). RS has an accreditation for animal research
given from Portuguese Veterinary Direction (Ministerial Directive
1005/92).
2.2. Parasites
A cloned line of virulent L. donovani (MHOM/IN/82/Patra1) was
maintained by weekly subpassages at 26 °C in RPMI 1640 medium
(Lonza, Swtzerland) supplemented with 10% heat-inactivated Fetal
Bovine Serum (FBS) (Lonza, Switzerland), 2 mM L-glutamine, 100 U/ml
penicillin, 100mg/ml streptomycin and 20mM HEPES buﬀer
(BioWhittaker, Walkersville, MD). Only L. donovani promastigotes
under four to ten passages were used in the experiments as previously
deﬁned [6]. To prepare soluble Leishmania donovani antigens (SLA),
50× 106 parasites were resuspended in 1ml of sterile PBS and 10 cy-
cles of freeze/thaw were performed. Total protein content was assessed
through BCA method.
2.3. In vivo infection
WT and pMT-10 mice were infected intraperitoneally with 20× 106
stationary-phase L. donovani promastigotes resuspended in apyrogenic
sterile PBS. IL-10 was induced by the administration of 2% sucrose
solution containing 50mM of zinc sulphate (Sigma) in the drinking
water as previously described [2]. WT mice received water with 2% of
sucrose, as a control. IL-10 induction in pMT-10 mice was performed at
early (0–12 days) and late (35–47 days) time points of infection
(Fig. 1A). Sixty days post-infection, the animals were euthanized and
the spleen, liver and blood were recovered for further biochemical and
histopathological analysis.
2.4. Parasite burden
DNA was extracted from spleen and liver homogenates using the
phenol-chloroform-isoamyl alcohol method. Parasite burden was as-
sessed as previously described [10], using a TaqMan-based qPCR assay
for detection and quantiﬁcation of L. donovani kinetoplastid DNA.
2.5. Flow cytometry analysis
Splenocytes were stimulated with SLA (10 μg/ml) during 18 h to
allow the proliferation and functional response of speciﬁc T cells.
Brefeldin A (10 μg/ml) was added during the last 3 h of SLA stimula-
tion. The anti-mouse monoclonal antibodies used to perform this study
were all purchased to BioLegend (CA, USA). Abs used include: FITC
Fig. 1. IL-10 overexpression at distinct time points of Leishmania donovani infection associates with distinct clinical outcomes. (A) pMT-10 and WT mice were
intraperitoneally infected with 20×106 L. donovani promastigotes. The pMT-10 (0–12) group received zinc supplementation from day 0 to 12 post-infection while
the pMT-10 (35–47) received from day 35 to 47 post-infection. WT mice were not supplemented with zinc through the course of infection. (B) All animals were
sacriﬁced at day 60 post-infection. Parasite burden in spleen and liver homogenates. (C) ALT and AST levels in the serum of infected animals. (D) H&E staining of
liver sections (5 μm). Data is shown as mean ± SD; n= 4–6 mice/group. One representative experiment is shown out of two. *p < 0.05; **p < 0.01; ***p < 0.001.
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anti-mouse TNF Ab, clone MP6-XT22; PerCP/Cy5.5 anti-mouse CD3,
clone 145-2C11; PeCy7 anti-mouse IFN-γ, clone XMG1.2; APC anti-
mouse IL-10; clone JES5-16E3; APC/Cy7 anti-mouse CD4, clone GK1.5;
BV421 anti-mouse IL-2, clone JES6-5H4; BV711 anti-mouse CD8, clone
53–6.7. Samples were acquired on a LSRII ﬂow cytometer (BD
Biosciences) and data analysed using FlowJo software (TreeStar).
Supplementary ﬁgure 1 depicts the identiﬁcation criteria used for se-
lecting the cellular populations of interest.
Supplementary data associated with this article can be found, in the
online version, at https://doi.org/10.1016/j.cyto.2018.07.001.
2.6. Histology
After mice euthanasia, the liver was perfused with saline solution
and ﬁxed with 10% (w/v) formalin. The sections were further dehy-
drated and embedded in paraﬃn for further histopathological analysis.
Samples were then sectioned for haematoxylin and eosin staining.
Bright ﬁeld images were acquired on a BX6 microscope.
2.7. ALT/AST quantiﬁcation
ALT and AST levels were quantiﬁed in the serum using an
AutoAnalyzer (Prestige 24i, PZ Cormay S.A) as previously described
[10].
2.8. IL-10 quantiﬁcation
IL-10 levels were quantiﬁed on blood, spleen and liver homogenates
by ELISA and the transcriptional levels of Il10 gene were assessed by
real-Time quantitative PCR (qRT-PCR). Brieﬂy, spleen and liver were
homogenized and stored for IL-10 quantiﬁcation using IL-10 mouse
uncoated ELISA kit (ThermoScientiﬁc) or in TRIreagent (Sigma-
Aldrich) for RNA extraction. Total RNA was extracted and the synthesis
of cDNA was made with SensiFAST™ cDNA Synthesis Kit (Bioline). qRT-
PCR reactions were run for each sample on a Bio-Rad CFX96 Real-Time
System C1000 Thermal Cycler (Bio-rad) using SensiFAST SYBR Hi-ROX
Kit (Bioline). Primer sequences were obtained from Alfagene (Portugal)
and thoroughly tested. The results were normalized to the expression of
the housekeeping gene ubiquitin. After ampliﬁcation, cycle threshold-
values (Ct-values) were calculated for all samples and gene expression
changes were analyzed in the CFX Manager Software (Bio-Rad). The
serum, splenic and liver IL-10 transcript and expression levels are
shown on Supplementary ﬁgure 2A and B respectively.
2.9. Statistical analysis
Statistical analyses were performed with the GraphPad Prism 6
software. A one-way analysis of variance (ANOVA) followed by a
Bonferroni’s post hoc test was employed for multiple group compar-
isons. Statistically signiﬁcant values are as follows: *p < 0.05,
**p < 0.01, ***p < 0.001.
Fig. 2. Early IL-10 overexpression leads to a loss of multifunctional CD4 T cells and lower IFN-γ/IL-10 ratios that associates with susceptibility. (A) Total CD4 and
CD8 T cells number in the spleen of infected mice. Number of IFN-γ-, IL-2-, TNF- and IL-10-producing CD4 T cells (B) and CD8 T cells (C). (D) IFN-γ/IL-10 ratio in CD4
and CD8 T cells. (E) Frequency of cytokine-producing CD4 T cells expressing each of the seven possible combinations of IFN-γ, IL-2 and TNF. (F) Fraction of the total
response of CD4 T cells comprising cells expressing all three (3+), two (2+) or one cytokine (1+). Data is shown as mean ± SD; n= 4–6 mice/group. One
representative experiment is shown out of two. *p < 0.05; **p < 0.01; ***p < 0.001.
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3. Results and discussion
To understand the temporal impact of IL-10 during the immune
response towards L. donovani, we used the pMT-10 mouse model in-
fected with L. donovani. IL-10 expression induced by the administration
of zinc supplementation in the water was controlled and induced at
diﬀerent time points during the infection. The IL-10 was overexpressed
from day 0 to 12 [pMT-10 (0–12)] or from day 35 to 47 [pMT-10
(35–47)] post-infection (Fig. 1A). We demonstrated that overexpression
of IL-10 during the initial 12 days of infection led to a signiﬁcantly
increased parasite burden at day 60 post-infection in the major para-
sitized organs, the spleen and the liver, when compared to WT and
pMT-10 (35–47) counterparts (Fig. 1B). In the presence or absence of
zinc supplementation in the drinking water, the parasite burdens of
C57BL/6 wt were similar disregarding any potential impact of zinc
supplementation on the immune response to Leishmania infection (data
not shown). The increased susceptibility displayed by pMT-10 (0–12)
animals was associated with increased serum levels of alanine transa-
minase (ALT) and aspartate transaminase (AST) (Fig. 1C), which are
biomarkers associated with hepatic toxicity [3]. Surprisingly, the
overexpression of IL-10 upon the 35th day of infection had no impact
on the visceral parasite burden nor on induced liver damage. Never-
theless, a larger number of complex inﬂammatory inﬁltrates were found
in the liver of infected pMT-10 (35–47) (Fig. 1D). The formation of
hepatic granulomas during Leishmania infection has been extensively
studied. It is currently known that at one week post-infection, T cells
are recruited to the granuloma to conﬁne parasitized resident Kupﬀer
cells and prevent parasite dissemination [11]. Overexpression of IL-10
in infected pMT-10 (35–47) displayed larger and more numerous in-
ﬁltrates than those observed in infected pMT-10 (0–12) mice, sug-
gesting that these might be associated with a lower parasite load when
compared to pMT-10 (0–12). Altogether, our results suggest that IL-10
overexpression later after infection, at a moment where the T cell re-
sponse is established, leads to an increased cellular mobilization to
achieve the same control as seen in WT mice. In opposition, over-
expression of IL-10 during the initial steps of the infection impacts host
ability to control L. donovani infection by limiting the development of a
protective adaptive immune response. To further address this issue, a
qualitative and quantitative analysis of splenic parasite-speciﬁc T cells
was performed at day 60 post-infection. Our results indicated that the
pMT-10 (35–47) group displayed a higher number of both CD4 and CD8
T cells in the spleen when compared to pMT-10 (0–12) and WT mice
(Fig. 2A), which is consistent with the inﬂammatory inﬁltrates observed
in the liver (Fig. 1D). Moreover, the infected pMT-10 (35–47) mice
displayed increased Leishmania-speciﬁc IFN-γ- and IL-2-producing CD4
(Fig. 2B) and CD8 T cells (Fig. 2C). Yet, this was accompanied by a
signiﬁcant increase on the number of IL-10-producing CD4 (Fig. 2B)
and CD8 T cells (Fig. 2C). In accordance with the observed suscept-
ibility to infection (Fig. 1B), the L. donovani-infected the pMT-10 (0–12)
group displayed lower number of TNF-α-producing CD4 and CD8 T
cells and higher number of IL-10-producing CD4 and CD8 T cells
(Fig. 2B-C). We and others have previously shown that increased IFN-γ/
IL-10 ratios are associated with protection against Leishmania infection
[12,9],. We observed that pMT-10 (0–12) with increased susceptibility
to L. donovani infection (Fig. 1B) are associated to a lower IFN-γ/IL-10
ratio compared to WT and pMT-10 (35–47) mice (Fig. 2D). We next
extended the analyses to multifunctional CD4 T cells. Strikingly, we
found a loss of CD4 T cells expressing both IFN-γ and IL-2 (2+) as well
of those expressing the three cytokines (3+ - IFN-γ+IL-2+TNF-α+) in
infected pMT-10 (0–12) compared to infected WT and pMT-10 (35–47)
mice (Fig. 2E). Thus, our results are consistent with the notion that
protection against distinct Leishmania species is accompanied by the
induction of Leishmania-speciﬁc multifunctional T cell response,
shifting qualitatively from single to triple producers Darrah et al. [15],
Selvapandiyan et al. (2009). Quantifying the fraction of the total cy-
tokine response comprising three (3+), any two (2+) or any one (1+)
cytokine, we found that over half of the response in the pMT-10 (0–12)
was in single-producers, whereas the response in the other groups were
dominated by double producer T cells (Fig. 2F). Overall, the early up-
regulation of IL-10 seems to be clearly associated with a decrease of
IFN-γ/IL-10 ratio in T cells dampening multifunctional CD4 T cells.
Such immunologic landscape contributes therefore for the establish-
ment of a successful infection.
4. Conclusions
In this work, we disclose a temporally-regulated role for IL-10
during the initial steps on infection, which impacts the pathogenesis of
VL. We demonstrate that the presence of high levels of IL-10 in the
initial phase of infection culminates in higher susceptibility, which is
mainly associated to the development of a permissive environment
characterized by a decreased frequency of multifunctional CD4 T cells.
Interestingly, our results highlight the role of IL-10 in the very early
phase of infection. Indeed, despite higher levels of IL-10 at the steady
state (days 35) and of IL-10 expressing CD4 and CD8 T cells, IFN-γ
remains elevated. As such, the overexpression of IL-10 upon the es-
tablishment of the adaptive immune response do not impact parasite
burden. Overall, this work shed some light on the temporal impact of
IL-10 on host immune responses against visceral leishmaniasis.
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